Bonus BioGroup Gains From Start Of Clinical Trials Of Stem Cell Derived Bone Grafts

– – Bonus Biogroup Ltd. (TASE: BONS), which has developed a method for producing bone grafts from stem cells, has begun a clinical trial of jawbone grafts. The trial’s interim results More...